OBJECTIVES: Identify the direct costs in angioplasty patients in private hospitals in Brazil. METHODS: It was selected patients from 3 (three) Brazilian states in the same operator who underwent angioplasty at private hospitals present in Orizon database. Parallely was followed the consumption of these medications during the same period by PBM (Pharmaceutical Benefit Management). RESULTS: A total of 196 patients were identified in a predominantly male population (76%) and above 59 years of age (65%) who underwent angioplasty and subsequently consumed drugs via PBM. We found that the average expenditure per patient with angioplasty with or without stenting in private hospitals corresponds to 5579.07 USD, while spending only with prosthesis corresponded to 13% of the drive. CONCLUSIONS: The treatment of coronary stenoses does not account only surgical procedures, but also the administration of medicines to control lipids, blood pressure, antidepressants and even hypoglycemia, and even then those expenditures does not consider the indirect expenses such as transportation and escort the patient to the hospital and absence from work.